Discover 1,398 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,398
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: 33 recruiting locations
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & Responsive
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: 13 recruiting locations
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06786624
Phase3, Recruiting
Active & Responsive
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
for
Generalized Anxiety Disorder
Location: 11 recruiting locations
Sponsor: Mind Medicine, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06809595
Phase3, Recruiting
Active & Responsive
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
for
Depressive Disorder, Major
Location: 30 recruiting locations
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 64
Code: NCT06785012
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: 18 recruiting locations
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06966401
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
for
Progressive Pulmonary Fibrosis
Location: 53 recruiting locations
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 21+
Code: NCT06025578
Phase3, Recruiting
Active & Responsive
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: 194 recruiting locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Active & Responsive
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: 63 recruiting locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Active & Responsive
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: 44 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.